Opportunities for the development of novel therapies based on host-microbial interactions

Pharmacol Res. 2016 Oct:112:68-83. doi: 10.1016/j.phrs.2016.04.005. Epub 2016 Apr 20.

Abstract

Immune responses are fundamental for protecting against most infectious agents. However, there is now much evidence to suggest that the pathogenesis and tissue damage after infection are not usually related to the direct action of the replication of microorganisms, but instead to altered immune responses triggered after the contact with the pathogen. This review article discusses several mechanisms necessary for the host to protect against microbial infection and focuses in aspects that cause altered inflammation and drive immunopathology. These basic findings can ultimately reveal pathways amenable to host-directed therapy in adjunct to antimicrobial therapy for future improved control measures for many infectious diseases. Therefore, modulating the effects of inflammatory pathways may represent a new therapy during infection outcome and disease.

Keywords: Host microbial interaction; Infection disease; Inflammatory response; Platelet-activating factor (PAF); Therapeutic potential targets.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Infective Agents / immunology
  • Anti-Infective Agents / pharmacology*
  • Anti-Infective Agents / therapeutic use*
  • Bacteria / drug effects
  • Bacteria / metabolism
  • Bacterial Infections / drug therapy
  • Bacterial Infections / immunology
  • Drug Discovery
  • Host-Pathogen Interactions*
  • Humans
  • Infections / drug therapy*
  • Infections / immunology*
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / metabolism
  • Inflammation / microbiology
  • Mice
  • Molecular Targeted Therapy
  • Mycoses / drug therapy
  • Mycoses / immunology
  • Virus Diseases / drug therapy
  • Virus Diseases / immunology
  • Viruses / drug effects
  • Viruses / metabolism

Substances

  • Anti-Infective Agents